Comment to: Dual effect hypothesis of insulin analogs on diabetic retinopathy
- PMID: 27488166
- PMCID: PMC4991190
- DOI: 10.4103/0301-4738.187693
Comment to: Dual effect hypothesis of insulin analogs on diabetic retinopathy
Comment on
-
Does tight control of systemic factors help in the management of diabetic retinopathy?Indian J Ophthalmol. 2016 Jan;64(1):62-8. doi: 10.4103/0301-4738.178146. Indian J Ophthalmol. 2016. PMID: 26953026 Free PMC article. Review.
References
-
- Kaya A, Kar T, Aksoy Y, Özalper V, Basbug B. Insulin analogues may accelerate progression of diabetic retinopathy after impairment of inner blood-retinal barrier. Med Hypotheses. 2013;81:1012–4. - PubMed
-
- Varewijck AJ, Goudzwaard JA, Brugts MP, Lamberts SW, Hofland LJ, Janssen JA. Insulin glargine is more potent in activating the human IGF-I receptor than human insulin and insulin detemir. Growth Horm IGF Res. 2010;20:427–31. - PubMed
-
- Adams DA, Rand RW, Roth NH, Dashe AM, Gipstein RM, Heuser G. Hypophysectomy in diabetic retinopathy. The relationship between the degree of pituitary ablation and ocular response. Diabetes. 1974;23:698–707. - PubMed
-
- Merimee TJ. A follow-up study of vascular disease in growth- hormone-deficient dwarfs with diabetes. N Engl J Med. 1978;298:1217–22. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
